Malaria is a major public health problem in Ethiopia, with 75 percent of the over 80 million inhabitants at risk for malaria epidemics.
Accurately quantifying antimalarial commodity requirements in Ethiopia is a challenge for multiple reasons. Transmission of malaria is highly variable and characterized by frequent and often large-scale epidemics. In addition, both artemisinin-based combination therapy (ACT) and rapid diagnostic tests (RDTs) have a short shelf life.
In October 2012, a dozen ONE Moms visited Ethiopia. During their visit, the moms visited many sites including farms, schools and health clinics sponsored by a number of governmental, international and non profit organizations that are having a transformational impact on the lives of women, their families and their communities.
By Nena Terrell
Last updated: March 10, 2014